Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tempel, C.
Right arrow Articles by Neeman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tempel, C.
Right arrow Articles by Neeman, M.
Agricola
Right arrow Articles by Tempel, C.
Right arrow Articles by Neeman, M.
Biology of Reproduction 63, 134-140 (2000)
© 2000 Society for the Study of Reproduction, Inc.


Regular article

Hyaluronic Acid as an Anti-Angiogenic Shield in the Preovulatory Rat Follicle1

Catherine Tempela, Assaf Gileada, and Michal Neeman2,a

a Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, 76100, Israel

ABSTRACT

Angiogenesis in the preovulatory follicle is confined to the theca cell layers, and penetration of capillaries through the basement membrane into the granulosa cell layers does not occur until after ovulation. However, elevated expression of the angiogenic growth factor (VEGF) has been reported in the cumulus cells surrounding the oocyte, which are expelled from the follicle during ovulation. This spatial and temporal discrepancy between VEGF expression and angiogenesis was studied here in the rat ovarian follicle, and we showed that cumulus cells secrete to the follicular fluid, in addition to VEGF, material with antiangiogenic activity that blocks endothelial cell proliferation, migration, and capillary formation in vitro. Hyaluronic acid produced by the cumulus cells can account for this antiangiogenic activity. Degradation of hyaluronic acid by hyaluronidase restored proliferation and migration of endothelial cells directed toward the cumulus. Inhibition of hyaluronic acid synthesis with 6-diazo-5-oxo-1-norleucine restored endothelial proliferation and migration in vitro, and it also resulted in early penetration of capillaries across the follicular basement membrane in vivo. These results support the role of hyaluronic acid produced by the cumulus cells as a high-molecular-weight, antiangiogenic shield that prevents premature vascularization of the preovulatory follicle by blocking endothelial cell migration and proliferation.

cumulus cells, follicular development, hCG, LH, ovary, ovulation

INTRODUCTION

Angiogenesis, a relatively rare process in normal adult organs, occurs during normal development of the ovarian follicle. During follicular growth, angiogenesis is restricted to the theca cell layer. New blood vessels penetrate the basement membrane of the follicle only after ovulation [1]. The newly formed capillaries surrounding the preovulatory follicle are highly permeable [1]. This elevated permeability can result from the effect of vascular endothelial growth factor (VEGF/VPF), which is highly expressed in the developing follicle [25].

A marked increase (~8-fold) in steady-state levels of the transcripts for VEGF120 and VEGF164 was measured between 1 and 4 h after administration with hCG in whole ovaries [2]. Increases were detectable mainly in the cumulus cells but also in the granulosa cells and in thecal/stromal tissue [4, 6, 7]. The high level of expression was maintained at 10 and 18 h (Day 1 corpus luteum) [2, 8, 9]. The pattern of expression in the preovulatory follicle suggests that hypoxic stress may contribute to VEGF expression in the inner cumulus cells surrounding the oocyte [2, 10], as has been reported previously for other systems [3, 6].

Based on the elevated expression of VEGF in the cumulus cells and the vascular sprouting observed in vivo at the theca cell layer of the maturing follicles, the follicular fluid should be proangiogenic. In vitro, media conditioned either by isolated intact follicles from unstimulated or hCG-stimulated rabbits increased endothelial cell migration. The chemoattractant activity was associated with a molecular weight of greater than 30 000, and it was not correlated with the steroid concentration in the medium [11]. Human follicular fluid, aspired during retrieval of oocytes for in vitro fertilization, has enhanced DNA synthesis in endothelial cells [12]. Angiogenic activity has also been demonstrated in the conditioned medium of cells from luteinized rat ovaries [13] and in extracts of nonluteal mice and porcine ovaries [14, 15]. In the latter study, no activity was observed in the follicular fluid.

The conflicting data regarding angiogenicity of the follicular fluid may be explained, in part, by the fact that some angiogenic activity may be modulated by oxygenation. Indeed, conditioned medium derived from oxygen-depleted cultures of rat granulosa cells (2% oxygen) caused elongation and alignment of bovine aortic endothelial cells and also promoted their proliferation [16], whereas in medium conditioned at 20% oxygen, endothelial cells showed a typical cobblestone morphology. In addition, some angiogenic activity of the follicular fluid has been attributed to glycosaminoglycans and degradation products of hyaluronic acid secreted into the antrum by the surrounding granulosa and cumulus cells [17].

Controversially, whereas elevated VEGF expression is detected in cumulus cells at the center of the follicle 4 h after the LH surge, angiogenesis during this period is restricted to the theca cells. Vessel penetration into the granulosa cell layers occurs later, after ovulation, when the VEGF-expressing cumulus-oocyte complex (COC) is expelled to the oviduct. Thus, secretion of VEGF is not followed by directed invasion of endothelial cells through the basement membrane into the follicle center. Moreover, such angiogenic activity, if it were to occur, could potentially interfere with ovulation by restricting the release of the oocyte.

This spatial and temporal discrepancy between VEGF expression and angiogenesis led us to suggest that within the preovulatory follicle, angiogenesis is blocked by a high-molecular-weight constituent of the follicular fluid. The goal of this study was to test the possibility that hyaluronic acid, which is produced by cumulus cells and secreted into the follicular fluid [1820], plays a role as an intrafollicular antiangiogenic shield. High-molecular-weight hyaluronic acid inhibits angiogenesis during development [21] and in tumors [22], whereas its products of degradation by hyaluronidase are angiogenic [23]. Hyaluronic acid is a major glycosaminoglycan of the extracellular matrix and is secreted specifically by the cumulus cells in the preovulatory follicle. Inhibition of hyaluronic acid synthesis by 6-diazo-5-oxo-1-norleucine (DON) prevents ovulation [18, 19 ].

MATERIALS AND METHODS

Materials

Calf serum was obtained from Hyclone (Logan, UT). Biogro 1, fetal calf serum, Dulbecco's Modified Eagle Medium (DMEM), penicillin, and streptomycin were purchased from Biological Industries (Kibbutz Beth Haemek, Israel). L-Glutamine and fungizone were obtained from Biolab Ltd. (Jerusalem, Israel), and ovine LH and hFSH were obtained from NHPP (Torrance, CA). [3H]Methyl-thymidine was purchased from Rotem Industries Ltd. (Beer Sheva, Israel). Collagen type I, eCG, DON (an inhibitor of hyaluronic acid synthesis), and hyaluronidase were obtained from Sigma Chemical Co. (St. Louis, MO), and hCG was from Organon (Holland). 4-Di-10-Asp [4-(4-(didecylamino)styryl)-N-methylpyridinium iodide] was obtained from Molecular Probes Inc. (Eugene, OR), and the scintillation fluid (ULTIMA GOLD) was from Packard Instrument Co. (Meriden, CT).

Endothelial Cell Culture

Fresh A19 bovine aortic endothelial cells [24] were kindly provided by Prof. I. Vlodavsky (Hadassah Medical Center, Jerusalem, Israel). These cells were cultured at 37°C in DMEM low glucose (1 g/L) supplemented with 10% calf serum, 1% L-glutamine, 1% Biogro-1, and antibiotics (penicillin, 100 U/ml; streptomycin, 0.1 mg/ml). Cells were maintained at 37°C in a 5% CO2 humidified incubator. Cells were dissociated with a solution of 0.05% trypsin, 0.02% EDTA, and 0.01 M sodium phosphate (pH, 7.4) and then were subcultured at a "split" ratio of 1:6 (v:v). The cells were used from passage 14 to 20.

Thymidine Incorporation

Cellular DNA was labeled with [3H]methyl-thymidine (5 µCi/ml) for 6 h. The medium was removed, and the cells were rinsed sequentially with methanol, chilled with 5% trichloroacetic acid and double-distilled water, and finally lysed with NaOH (0.5 M). Radioactive label was counted in an LKB Wallac counter (Turku, Finland) using scintillation fluid.

Plate Coating with Collagen

Rat tail collagen type I (3 mg/ml) was dissolved in 0.0175 M acetic acid in double-distilled water at 4°C. The collagen solution was dialyzed (24 h, 4°C) against excess (1:1100) of DMEM:double-distilled water (1:10; pH, 4). The collagen was then mixed with 0.15 M NaHCO3 and 10x DMEM in ratio of 7:2:1. Culture plates were coated with a thin layer of collagen, and the collagen was then solidified by incubation at 37°C for approximately 10 min.

Animal Handling

Immature, 23-day-old female Wistar rats (from the Wistar colony of the Department of Biological Regulation, Weizmann Institute, Israel) were stimulated to superovulate by eCG (15 U subcutaneously) as described elsewhere [25]. Forty-eight hours later, follicular maturation was induced by injection of human hCG (5 U intraperitoneally), mimicking the action of the endogenous surge of LH in the induction of ovulation. Thus, all the follicles will synchronously differentiate and mature, and the time of ovulation will be predictable (9–12 h after administration of hCG). Animal studies were conducted in accordance with the Guiding Principles for the Care and Use of Research Animals.

Isolation of Follicular Fluid

Five hours after hCG stimulation, rat ovaries were excised and punctured in DMEM culture medium (glucose, 1 g/L; 1% glutamine; 1% Biogro-1; penicillin, 100 U/mL, and streptomycin, 0.1 ng/ml; two ovaries in 1 ml). The medium was collected and centrifuged for 5 min (1000 rpm), and the supernatant was added to culture wells (160 µl/well in a total volume of 0.5 ml of medium; ~30% of the follicular fluid extracted from one ovary was added per well).

Isolation of COCs

Immature COCs from eCG-primed rats or maturing COCs from eCG/hCG-primed female rats were recovered by puncturing selectively the largest follicles in Leibovitz L15 culture medium supplemented with 5% fetal calf serum and antibiotics (penicillin, 50 IU/ml; streptomycin, 50 µg/ml; fungizone, 125 µg/ml). Matured COCs were also extracted from the ampula of the oviduct 24 h after hCG stimulation. The COCs were then aspirated with a capillary under the binocular and were passed several times into new medium to reduce granulosa cell contamination.

Fluorescent Staining of the Endothelial Cells

4-Di-10-Asp, a lipophilic tracer, was dissolved in ethanol at 1 mg/ml. Endothelial cells were incubated at 37°C with 4-Di-10-Asp (40 µg/ml) for 35 min. Excess dye was removed by washing the cells with culture medium. The cells remained fluorescent for several days.

Coculture of Endothelial Cells with COCs

Bovine aortic endothelial cells were seeded in 96- or 24-well plates (70 or 350 cells/mm2 in DMEM medium) and incubated for 6 h to allow cells to adhere to the plate. The COCs (n = 1–10) were then added to the wells. Glutamine (10-2 mg/ml) was present in sufficient quantity to allow hyaluronic acid synthesis by the cumulus cells. Human FSH (12.5 µg/ml) or ovine LH (5 µg/ml) was used for promoting the expansion of COCs [26]. Treatments included hyaluronidase (600 µg/ml) and DON (58 µM). The cocultures were studied by thymidine uptake and direct microscopic observation of the endothelial cells. For direct observation, the endothelial cells were prestained with the vital fluorescent dye as described previously.

In Vivo Inhibition of Hyaluronic Acid Synthesis

Immature eCG-primed rats were injected intraperitoneally with DON (35 µg/g BW) at two time-points: first at 1 h before hCG injection, and then again 6–7 h after administration of hCG. Rats were killed 7–9 h after hCG injection. Histological sections (5 µm) of the ovaries were stained with eosin, hematoxylin, and light green for visualization of the cytoplasm and connective tissue. In addition, adjacent sections were used for endothelial cell-specific BS-1 staining [27].

Statistical Methods

Data are reported as the mean ± SEM. Statistical significance was determined by Student's t-test or ANOVA (Fisher's post hoc probabilistic least significant difference). Experimental values were considered to be significant at P < 0.05.

RESULTS

Follicular Fluid Can Induce and Suppress Endothelial Cell Proliferation

Follicular fluid derived 5 h after administration of hCG affected the proliferation of bovine aortic endothelial cells in a complex manner that depended on the proliferative status of those cells (Fig. 1A). Endothelial cell proliferation was measured by [3H]thymidine incorporation 24 or 48 h after addition of the follicular fluid. In growth-arrested endothelial cells obtained by incubation with serum-free medium containing 0.5% BSA (serum starvation condition), follicular fluid significantly stimulated the proliferation of serum-starved endothelial cells (P = 0.02; Fig. 1A). However, when follicular fluid was applied to proliferating endothelial cells cultured in presence of 10% calf serum, it significantly inhibited their proliferation (P = 0.002 and 0.016 for 24 and 48 h, respectively; Fig. 1A).



View larger version (32K):
[in this window]
[in a new window]
 
FIG. 1. The effect of the follicular fluid and isolated COCs on endothelial cell proliferation. Thymidine incorporation of endothelial cells was measured. A) Follicular fluid was inhibitory to proliferating endothelial cells (P = 0.002 and 0.016 for 24 and 48 h, respectively; triplicate measurements per treatment; three experiments) and stimulatory to proliferation of serum-starved bovine aortic endothelial cells (P = 0.02 for 24 and 48 h; triplicate measurements per treatment; three experiments). B) Inhibition of endothelial cell proliferation by maturing COCs (P = 0.02; two-tailed paired Student's t-test; six independent experiments, 3–4 wells per treatment in each experiment; 10 ± 2 COCs/well). Experiments 1, 2, 4, and 6: COCs triggered to mature in vitro with LH; experiment 3: COCs triggered to mature in vivo by hCG injection; experiment 5: matured COCs extracted from the ampula of the oviduct 24 h after in vivo hCG stimulation. Thymidine incorporation was measured after 24 h of coculture

Inhibition of Endothelial Cell Proliferation by Maturing COCs

To test whether the antiangiogenic activity resulted from the cumulus cells that surround the oocyte, endothelial cells were cocultured with COCs (10 ± 2 per well; Fig. 1B). Immature COCs from eCG-primed rats were cocultured with endothelial cells for 24 h in the presence of serum. Both immature COCs, which were triggered by gonadotropins to mature in vitro (experiments 1, 2, 4, 6) or in vivo (experiment 3), and matured COCs extracted from the ampula (experiment 5) significantly reduced thymidine incorporation in the endothelial cells (P = 0.005, two-tailed paired Student's t-test, six independent experiments, 3–4 wells per treatment in each experiment; Fig. 1B). Control experiments verified that thymidine incorporation was undetectable in COCs cultured under identical conditions in the absence of endothelial cells.

Hyaluronic Acid Dictates the Spatial Distribution of Endothelial Cells Cocultured with COCs

Endothelial cells prestained with the fluorescent vital dye 4-Di-10-Asp were cultured with COCs from eCG/hCG-primed rats (2 h after hCG, triplicates in two experiments). After 24 h, endothelial cells cultured with COCs surrounded the COCs at a distance and did not approach the cumulus cells (Fig. 2, A and B). These results further support the production of antiangiogenic material by COCs. After stimulation with hCG/LH, COC cells secrete high-molecular-weight hyaluronic acid. To test whether the antiangiogenic activity could be attributed to hyaluronic acid, we checked the distribution of endothelial cells among cocultures in which the levels of hyaluronic acid were perturbed either by its degradation with hyaluronidase or by inhibition of hyaluronic acid synthesis using DON. Endothelial cells cocultured with COCs and treated with either hyaluronidase or DON proliferated and migrated toward the cumulus cells (Fig. 2, C–F). Similar results were obtained using COCs derived from eCG-primed rats that were stimulated in vitro with ovine LH (5 µg/ml; data not shown).



View larger version (188K):
[in this window]
[in a new window]
 
FIG. 2. Coculture of COCs and endothelial cells. Endothelial cells were prestained with the fluorescent vital stain Di-Asp. The COCs were derived from eCG/hCG-primed rats (2 h after administration of hCG). Experiments were performed during 24 h. A and B) Control. Endothelial cells remained distant from the COC. C and D) Hyaluronidase-treated culture. Endothelial cell growth was stimulated, and the cells were found closer to the COC. E and F) DON-treated culture. Endothelial cell growth was stimulated, and the cells were found even closer to the COC. + marks the center of the oocyte. A, C, and E) Bright-field. B, D, and F) Fluorescence

The distance of the nearest 15 endothelial cells from the center of the oocyte was measured 24 h after treatment (one COC per well, 12 wells per treatment in two experiments). From these data, we calculated the density of endothelial cells (i.e., cells/unit area) as a function of the distance from the oocyte or the COC center (Fig. 3 and Table 1). In the absence of LH, the endothelial cell distribution was equal from 1 to 5 mm from the oocyte center. Thus, endothelial cells cocultured with control, nonmaturing COCs showed a homogeneous distribution, and the average endothelial distance (for the closest 15 endothelial cells) was 2.9 ± 0.1 mm. In the presence of LH, the endothelial cells tended to stay far from the COC center, and the mean cell distance was 3.2 ± 0.08 mm (P = 0.0078). When either DON or hyaluronidase were added, a significant decrease occurred in the mean distance (2.6 ± 0.1 mm and 2.19 ± 0.13 mm, respectively; P = 0.0001 for both). Treatment with DON restored the homogeneous endothelial cell distribution that was lost in the presence of LH, whereas hyaluronidase induced endothelial cells to migrate and proliferate toward the COC (Fig. 3 and Table 1).



View larger version (73K):
[in this window]
[in a new window]
 
FIG. 3. Distribution of endothelial cells from the center of the oocyte 24 h after treatment. The COCs derived from eCG-primed rats were stimulated in vitro with ovine LH (5 µg/ml) and cocultured with fluorescent endothelial cells (see example in Fig. 2). For each COC, the distance of the 15 closest endothelial cells was measured (see Table 1). Cell density (CD) was derived by dividing the number of cells (n) in each 1-mm ring by the area of that ring. (For a ring defined by the radius r1 and r2, CD = n/({pi}(r22 - r12)).) Without LH, the endothelial cells were distributed randomly. With LH, endothelial cells remained distant from the COC, with the maximal endothelial cell density occurring at 3–4 mm. With DON or hyaluronidase, the endothelial cells were found closer to the COC (n = 5). Note that the low density of cells at the outer rings of COCs treated with DON or hyaluronidase results from only the 15 closest cells being counted in each case (see Table 1)


View this table:
[in this window]
[in a new window]
 
TABLE 1. Distribution of endothelial cells cocultured with COC for 24 h

Endothelial Cell Migration and Capillary Formation Are Regulated by COC Secretion of Hyaluronic Acid

Endothelial cells prelabeled with the vital stain 4-Di-10-Asp were cultured on collagen, an extracellular matrix that permits them to migrate, differentiate, and form capillary-like structures. Endothelial cells were observed by fluorescent microscopy every 24 h for 4 days (Fig. 4). At 24 h, endothelial cells cocultured with maturing COCs already remained at a distance and were tangential to the COCs (Fig. 4). However, inhibition of hyaluronic acid synthesis with DON, or its degradation with hyaluronidase, resulted in endothelial cell migration and formation of multiple elongated, capillary-like structures directed toward the cumulus (Fig. 4).



View larger version (122K):
[in this window]
[in a new window]
 
FIG. 4. Effect of hyaluronidase and DON on endothelial cell migration. The COCs were derived from eCG/hCG-primed rats (2 h after administration of hCG). Endothelial cells were prestained with the fluorescent vital stain Di-Asp and cultured on collagen. A) Cocultures 4 days after addition of COCs. The fluorescent images were overlayed in green on gray-scale, bright-field images to highlight the endothelial cells. Note the rounded and tangential morphology of the endothelial cells in control cultures and the radial morphology in DON- and hyaluronidase-treated cultures. The blurred background fluorescence results from out-of-focus endothelial cells in the three-dimensional collagen culture. B) Cocultures 1 day after addition of COC. Arrows mark the endothelial cells. In the control culture (left), note that most endothelial cells are tangential to the COC, leaving a zone that is clear of endothelial cells. In the DON-treated cumulus (right), note the radial layout of the endothelial capillary-like extensions. C) High-magnification views of an endothelial cell extending tangentially to a control COC (left) and an endothelial cell infiltrating toward a DON-treated COC (right)

Hyaluronic Acid Synthesis Suppresses Follicular Angiogenesis In Vivo

The effect of hyaluronic acid in remodeling of the preovulatory follicular vasculature was also analyzed by perturbing its synthesis in vivo. Histological ovarian sections from rats treated with DON were obtained 3 h before ovulation (7 h after hCG administration), which is before the normal reported time of basement membrane breakdown (Fig. 5). In sections of control, untreated ovaries, we observed that the cumulus oophorus was dispersed, indicating the presence of hyaluronidase-sensitive material [26]. The basement membrane (shown in green) was intact and displayed a well-defined barrier between the granulosa and theca cell layers. In contrast, ovaries of rats treated with DON contained a dense cumulus oophorus, and the basement membrane was partially degraded, showing vague separation between the granulosa and theca cell layers (Fig. 5). Endothelial capillaries that penetrated the basement membrane were counted as well, and the mean number of lectin-positive capillaries per follicle was significantly lower in control follicles (1.51 ± 0.4, n = 13) than in follicles treated with DON (3.25 ± 0.9, n = 9, P = 0.03, Student's t-test). Thus, inhibition of hyaluronic acid synthesis resulted in significant premature angiogenesis toward the center of the follicle.



View larger version (117K):
[in this window]
[in a new window]
 
FIG. 5. In vivo effects from the inhibition of hyaluronic acid synthesis on angiogenesis of the ovary. Sections of ovaries were obtained 7 h after hCG injection. A, C, and G) Control ovaries. B, D, E, F, and H) Injection of DON, an inhibitor of glucosamine synthesis. Eosin-hematoxylin, light-green staining (A–F) shows the basement membrane (green) and erythrocytes (red), and BS-1 stain (G and H) shows the endothelial cells. For DON-treated ovaries, early degradation of the basement membrane was observed, along with infiltration of endothelial cells into the granulosa cell layers of the preovulatory follicles. Arrowheads mark the basement membrane, and arrows point toward infiltrating capillaries. G, Granulosa cell layer; T, theca cell layer

DISCUSSION

The present work aimed to explain the temporal and spatial discrepancy between the induced expression of VEGF and the restricted angiogenesis in the preovulatory follicle. After the LH surge, VEGF expression is elevated in the cumulus cells at the center of preovulatory follicles, and during this period, angiogenesis is confined to the theca interna. Subsequent infiltration of capillaries to the center of the follicle occurs only after the COC was expelled. In late preovulatory follicles and the postovulatory corpus luteum, where angiogenesis is ongoing, both VEGF and angiopoietin 2 are up-regulated, whereas angiopoietin 1 expression persists [7, 9, 28]. Angiopoietin 2 expression appears to be punctate, or focal. Transcripts of angiopoietin 2 were clustered in close association with blood vessels in the theca interna of the late preovulatory follicle. Angiopoietin 2 may collaborate with VEGF at the front of invading vascular sprouts by blocking a constitutive stabilization or maturing function of angiopoietin 1, thus allowing vessels to revert to, and to remain in, a more plastic state, in which they may be more responsive to a sprouting signal provided by VEGF.

These facts suggest that the new sprouts should invade the follicle even before ovulation. One possibility is that angiogenesis is blocked by the basement membrane. However, VEGF-activated endothelial cells can degrade basement membrane, and in fact, collagenolytic degradation of the basement membrane is an integral part of follicular rupture leading to ovulation [20, 29]. We hypothesize here that hyaluronic acid produced by the cumulus cells provides a high-molecular-weight antiangiogenic shield that prevents premature vascularization of the preovulatory follicle by blocking endothelial cell migration and proliferation. To test this hypothesis, we analyzed endothelial cells cultured in vitro with COCs and monitored angiogenesis in vivo among rats in which hyaluronic acid synthesis was suppressed.

Follicular fluid stimulated the proliferation of serum-starved endothelial cells, but it also suppressed the proliferation of endothelial cells cultured with serum. The induced proliferation of serum-starved endothelial cells is consistent with the presence of VEGF [30] and plasma proteins in the follicular fluid [31]. The inhibitory effect of follicular fluid on proliferating endothelial cells suggests that follicular fluid contains, in addition to proangiogenic molecules, a negative regulator of angiogenesis. Thus, the follicular fluid, which is a serum exudate, probably contains both pro- and antiangiogenic molecules. That COCs inhibited endothelial cell proliferation and migration suggests that COC cells are the source for the antiangiogenic activity. The antiangiogenic activity observed in vitro in the presence of COCs could be suppressed by hyaluronidase, which degrades hyaluronic acid, or by DON, which inhibits hyaluronic acid synthesis.

DON is an effective inhibitor of glucosamine synthesis. It binds with and inactivates the aminotransferase that transfers an amino group from glutamine to fructose-6-P, thus inhibiting the formation of glucosamine-6-P [32]. The volumetric increase of the cumulus mass in the presence of the substrates of hyaluronic acid synthesis is directly proportional to the amount of hyaluronic acid synthesized by these cultured COCs [19]. Cumulus expansion in the eCG/hCG-stimulated rat occurs between 2.5 and 5 h after the ovulatory stimulus [33], and by approximately 5 h after stimulation, the volume of the cultured COC increases almost 40-fold. This expansion can be inhibited both in vitro or in vivo by the administration of DON [19].

Endothelial cell migration and capillary formation on collagen were inhibited by COCs, and this inhibitory effect could be suppressed using hyaluronidase or DON. Thus, capillary-like endothelial structures remained at a distance and tangential to the control COC, whereas capillary-like structures were radial and infiltrated into COCs treated with hyaluronidase or DON. Likewise, in vivo administration of DON led to early infiltration of endothelial cells through the basement membrane and into the granulosa cell layers.

Angiogenesis is frequently controlled by a balance of pro- and antiangiogenic regulators [34]. In the preovulatory follicle, we suggest that the spatial and temporal regulation of angiogenesis is maintained through a balance between secretion of diffusible proangiogenic VEGF, which stimulates angiogenesis and permeability in the perifollicular vasculature, and secretion of high-molecular-weight antiangiogenic hyaluronic acid, which prevents vascular sprouting locally into the growing follicle. Induction of VEGF expression is essential for improving perfusion to the follicular periphery and reducing metabolic stress for the oocyte [35]. The VEGF-activated endothelial cells also may contribute to collagenase activity and dissolution of the basement membrane in preparation for ovulation. We argue here that along with the induction of VEGF and initiation of vascular sprouting, it is essential to inhibit angiogenesis locally within the growing follicle to ensure that the oocyte remains unrestrained. Local inhibition of angiogenesis is achieved by secretion of hyaluronic acid, which is a solid, high-molecular-weight gel that can specifically inhibit vascular infiltration in the confined space of the follicular fluid.

ACKNOWLEDGMENTS

We would like to thank Prof. Nava Dekel and Prof. Alex Tsafriri for helpful discussions. Gonadotropin hormones were obtained through the National Hormone and Pituitary Program.

FOOTNOTES

First decision: 11 May 1999.

1 Supported by a research grant from the MINERVA Foundation and by NIH grant CA75334-01A1. M.N. is incumbent of a Career Development Award from the Israel Cancer Research Foundation. Back

2 Correspondence. FAX: 972 8 9344116; lhneeman{at}wicc.weizmann.ac.il Back

Accepted: February 22, 2000.

Received: April 14, 1999.

REFERENCES

  1. Cavender JL, Murdoch WJ. Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod 1988; 39:989–997.[Abstract]
  2. Koos RD. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following and ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol Reprod 1995; 52:1426–1435.[Abstract]
  3. Shweiki D, Itin A, Neufeld G, Gitay Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91:2235–2243.
  4. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996; 81:353–359.[Abstract]
  5. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 1998; 13:953–959.[Abstract/Free Full Text]
  6. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 1995; 92:768–772.[Abstract/Free Full Text]
  7. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2: a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55–60.[Abstract/Free Full Text]
  8. Ravindranath N, Little Ihrig L, Phillips HS, Ferrara N, Zeleznik AJ. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 1992; 131:254–260.[Abstract/Free Full Text]
  9. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 1998; 78:1385–1394.[Medline]
  10. Neeman M, Abramovitch R, Schiffenbauer YS, Tempel C. Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Pathol 1997; 78:57–70.[CrossRef][Medline]
  11. Rone JD, Halvorson LM, Goodman AL. Ovarian angiogenesis in rabbits: endotheliotrophic chemoattractant activity from isolated follicles and dispersed granulosa cells. J Reprod Fertil 1993; 97:359–365.[Abstract/Free Full Text]
  12. Rose BI, Koos RD. The effect of human follicular fluid on endothelial cells: proliferation and DNA synthesis. Biol Reprod 1988; 39:88–95.[Abstract]
  13. Rone JD, Goodman AL. Preliminary characterization of angiogenic activity in media conditioned by cells from luteinized rat ovaries. Endocrinology 1990; 127:2821–2828.[Abstract/Free Full Text]
  14. Makris A, Ryan KJ, Yasumizu T, Hill CL, Zetter BR. The nonluteal porcine ovary as a source of angiogenic activity. Endocrinology 1984; 115:1672–1677.[Abstract/Free Full Text]
  15. Sato E, Ishibashi T, Koide SS. Inducement of blood vessel formation by ovarian extracts from mice injected with gonadotropins. Experientia 1982; 38:1248–1249.[CrossRef][Medline]
  16. Koos RD. Stimulation of endothelial cell proliferation by rat granulosa cell-conditioned medium. Endocrinology 1986; 119:481–489.[Abstract/Free Full Text]
  17. Sato E, Miyamoto H, Koide SS. Hyaluronic acid-like substance from mouse ovaries with angiogenic activity. Z Naturforsch C 1990; 45:873–880.
  18. Chen L, Russell RT, Larsen WJ. Functional significance of cumulus expansion in the mouse: roles for the preovulatory synthesis of hyaluronic acid within the cumulus mass. Mol Reprod Dev 1993; 34:87–93.[CrossRef][Medline]
  19. Chen L, Wert SE, Hendrix EM, Russell PT, Cannon M, Larsen WJ. Hyaluronic acid synthesis and gap junction endocytosis are necessary for normal expansion of the cumulus mass. Mol Reprod Dev 1990; 26:236–247.[CrossRef][Medline]
  20. Tsafriri A. Ovulation as a tissue remodelling process. Proteolysis and cumulus expansion. Adv Exp Med Biol 1995; 377:121–140.[Medline]
  21. Feinberg RN, Beebe DC. Hyaluronate in vasculogenesis. Science 1983; 220:1177–1179.[Abstract/Free Full Text]
  22. Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer 1995; 60:632–636.[Medline]
  23. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, Markowitz S, Willson J, Sy MS. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1996; 93:7832–7837.[Abstract/Free Full Text]
  24. Vlodavsky I, Fielding PE, Fielding CJ, Gospodarowicz D. Role of contact inhibition in the regulation of receptor-mediated uptake of low density lipoprotein in cultured vascular endothelial cells. Proc Natl Acad Sci U S A 1978; 75:356–360.[Abstract/Free Full Text]
  25. Tempel C, Schiffenbauer YS, Meir G, Neeman M. Modulation of water diffusion during gonadotropin-induced ovulation: NMR microscopy of the ovarian follicle. Magn Reson Med 1995; 34:213–218.[Medline]
  26. Dekel N, Philips DM. Maturation of the rat cumulus oophorus. A scanning electron microscopy study. Biol Reprod 1979; 21:9–18.[Abstract]
  27. Alroy J, Goyal V, Skutelsky E. Lectin histochemistry of mammalian endothelium. Histochemistry 1987; 86:603–607.[CrossRef][Medline]
  28. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277:48–50.[Free Full Text]
  29. Hirsch B, Leonhardt S, Jarry H, Reich R, Tsafriri A, Wuttke W. In vivo measurement of rat ovarian collagenolytic activities. Endocrinology 1993; 133:2761–2765.[Abstract/Free Full Text]
  30. Van Blerkom J, Antcczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997; 12:1047–1055.
  31. MacNatty KP. Follicular fluid. In: Jones RE (ed.), The Vertebrate Ovary. New York: Plenum Press; 1978: 215–259.
  32. Bates CJ, Adams WR, Handschumacher RF. Control of the formation of uridine diphospho-N-acetyl-hexosamine and glycoprotein synthesis in rat liver. J Biol Chem 1966; 241:1705–1712.[Abstract/Free Full Text]
  33. Larsen WJ, Wert SE, Brunner GD. A dramatic loss of cumulus cell gap junctions is correlated with germinal vesicle breakdown in rat oocytes. Dev Biol 1986; 113:517–521.[CrossRef][Medline]
  34. Hanahan K, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorogenesis. Cell 1996; 86:33–364.
  35. Chui DKC, Pugh ND, Walker SM, Gregory L, Shaw RW. Follicular vascularity—the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum Reprod 1997; 12:191–196.



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Krishnan, J. B. Hoying, H. Nguyen, H. Song, and J. A. Weiss
Interaction of angiogenic microvessels with the extracellular matrix
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3650 - H3658.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Shiftan, T. Israely, M. Cohen, V. Frydman, H. Dafni, R. Stern, and M. Neeman
Magnetic Resonance Imaging Visualization of Hyaluronidase in Ovarian Carcinoma
Cancer Res., November 15, 2005; 65(22): 10316 - 10323.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R Gruemmer, L Klein-Hitpass, and J Neulen
Regulation of gene expression in endothelial cells: the role of human follicular fluid
J. Mol. Endocrinol., February 1, 2005; 34(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
H. Zhang, S. L. Baader, M. Sixt, J. Kappler, and U. Rauch
Neurocan-GFP Fusion Protein: A New Approach to Detect Hyaluronan on Tissue Sections and Living Cells
J. Histochem. Cytochem., July 1, 2004; 52(7): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Schoenfelder and R. Einspanier
Expression of Hyaluronan Synthases and Corresponding Hyaluronan Receptors Is Differentially Regulated During Oocyte Maturation in Cattle
Biol Reprod, July 1, 2003; 69(1): 269 - 277.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tempel, C.
Right arrow Articles by Neeman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tempel, C.
Right arrow Articles by Neeman, M.
Agricola
Right arrow Articles by Tempel, C.
Right arrow Articles by Neeman, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS